ACOG Statement on US Supreme Court Decision on Patenting of Genes
June 14, 2013
Washington, DC -- The American Congress of Obstetricians and Gynecologists (ACOG) is heartened by the United States Supreme Court’s ruling that genes cannot be patented. This verdict hopefully will result in more options for women with regard to genetic testing for the breast cancer BRCA1 and BRCA2 gene mutations, as well as decrease the associated costs. In sum, this decision should help promote further scientific investigation in this area and ultimately benefit all patients.
The American College of Obstetricians and Gynecologists (The College), a 501(c)(3) organization, is the nation’s leading group of physicians providing health care for women. As a private, voluntary, nonprofit membership organization of more than 57,000 members, The College strongly advocates for quality health care for women, maintains the highest standards of clinical practice and continuing education of its members, promotes patient education, and increases awareness among its members and the public of the changing issues facing women’s health care. The American Congress of Obstetricians and Gynecologists (ACOG), a 501(c)(6) organization, is its companion organization. www.acog.org